These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


247 related items for PubMed ID: 19056653

  • 1. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells.
    Degner SC, Papoutsis AJ, Selmin O, Romagnolo DF.
    J Nutr; 2009 Jan; 139(1):26-32. PubMed ID: 19056653
    [Abstract] [Full Text] [Related]

  • 2. Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.
    Tomblin JK, Arthur S, Primerano DA, Chaudhry AR, Fan J, Denvir J, Salisbury TB.
    Biochem Pharmacol; 2016 Apr 15; 106():94-103. PubMed ID: 26944194
    [Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 promoter activation by the aromatic hydrocarbon receptor in breast cancer mcf-7 cells: repressive effects of conjugated linoleic acid.
    Degner SC, Kemp MQ, Hockings JK, Romagnolo DF.
    Nutr Cancer; 2007 Apr 15; 59(2):248-57. PubMed ID: 18001219
    [Abstract] [Full Text] [Related]

  • 4. BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells.
    Papoutsis AJ, Borg JL, Selmin OI, Romagnolo DF.
    J Nutr Biochem; 2012 Oct 15; 23(10):1324-32. PubMed ID: 22197621
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells.
    Das S, Somisetty VS, Ulven SM, Matthews J.
    Int J Mol Sci; 2023 Sep 26; 24(19):. PubMed ID: 37834026
    [Abstract] [Full Text] [Related]

  • 6. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
    Forrester AR, Elias MS, Woodward EL, Graham M, Williams FM, Reynolds NJ.
    J Dermatol Sci; 2014 Jan 26; 73(1):10-22. PubMed ID: 24161567
    [Abstract] [Full Text] [Related]

  • 7. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J, Wihlén B, Thomsen J, Gustafsson JA.
    Mol Cell Biol; 2005 Jul 26; 25(13):5317-28. PubMed ID: 15964790
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the mouse Cyp1B1 gene. Identification of an enhancer region that directs aryl hydrocarbon receptor-mediated constitutive and induced expression.
    Zhang L, Savas U, Alexander DL, Jefcoate CR.
    J Biol Chem; 1998 Feb 27; 273(9):5174-83. PubMed ID: 9478971
    [Abstract] [Full Text] [Related]

  • 9. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
    Ciolino HP, Daschner PJ, Yeh GC.
    Biochem J; 1999 Jun 15; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
    [Abstract] [Full Text] [Related]

  • 10. Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor.
    Lakhman SS, Chen X, Gonzalez-Covarrubias V, Schuetz EG, Blanco JG.
    Mol Pharmacol; 2007 Sep 15; 72(3):734-43. PubMed ID: 17569794
    [Abstract] [Full Text] [Related]

  • 11. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
    Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF.
    Cancer Res; 2006 Feb 15; 66(4):2224-32. PubMed ID: 16489025
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.
    Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF.
    J Nutr; 2010 Sep 15; 140(9):1607-14. PubMed ID: 20631324
    [Abstract] [Full Text] [Related]

  • 13. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells.
    Chen I, Safe S, Bjeldanes L.
    Biochem Pharmacol; 1996 Apr 26; 51(8):1069-76. PubMed ID: 8866829
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
    Vorrink SU, Severson PL, Kulak MV, Futscher BW, Domann FE.
    Toxicol Appl Pharmacol; 2014 Feb 01; 274(3):408-16. PubMed ID: 24355420
    [Abstract] [Full Text] [Related]

  • 15. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI.
    Mol Cell Endocrinol; 1999 Nov 25; 157(1-2):105-19. PubMed ID: 10619402
    [Abstract] [Full Text] [Related]

  • 16. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention.
    Okino ST, Pookot D, Basak S, Dahiya R.
    Cancer Prev Res (Phila); 2009 Mar 25; 2(3):251-6. PubMed ID: 19223575
    [Abstract] [Full Text] [Related]

  • 17. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
    Klinge CM, Kaur K, Swanson HI.
    Arch Biochem Biophys; 2000 Jan 01; 373(1):163-74. PubMed ID: 10620335
    [Abstract] [Full Text] [Related]

  • 18. Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c1c7.
    Fretland AJ, Safe S, Hankinson O.
    Chem Biol Interact; 2004 Nov 20; 150(2):161-70. PubMed ID: 15535986
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.